Efficacy and Safety of Targeting Androgen Receptor in Advanced Breast Cancer: A Systematic Review
Conclusion: Androgen receptor pathway targeting in advanced breast cancer remains a valid option with reasonable clinical benefit in non-selected patients. Future studies are needed to define an AR addicted cohort with better responses and outcome.
Source: Current Cancer Therapy Reviews - Category: Cancer & Oncology Source Type: research
More News: Addiction | Breast Cancer | Cancer | Cancer & Oncology | Cancer Therapy | Clinical Trials | Databases & Libraries | Hormones | Politics | Study